Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MDV3100”

303 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 303 results

Large-scale testing (Phase 3)Looking for participantsNCT07028853
What this trial is testing

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Who this might be right for
Metastatic Castration Sensitive Prostate Cancer (mCSPC)Hormone Sensitive Prostate CancerProstate Cancer+1 more
Pfizer 1,000
Early research (Phase 1)Study completedNCT03207529
What this trial is testing

Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+15 more
M.D. Anderson Cancer Center 18
Large-scale testing (Phase 3)Ended earlyNCT03850795
What this trial is testing

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer MetastaticCastration-resistant Prostate Cancer
Hinova Pharmaceuticals USA, Inc. 104
Testing effectiveness (Phase 2)Ended earlyNCT03764540
What this trial is testing

Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide

Who this might be right for
Metastatic Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 57
Testing effectiveness (Phase 2)Study completedNCT04332744
What this trial is testing

Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)

Who this might be right for
Metastatic Prostate Cancer
MedSIR 54
Testing effectiveness (Phase 2)Study completedNCT02007512
What this trial is testing

Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Pfizer 247
Testing effectiveness (Phase 2)Study completedNCT03336983
What this trial is testing

Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients

Who this might be right for
Prostate CancerBone Metastases
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT02955394
What this trial is testing

Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer

Who this might be right for
Breast Cancer
University of Colorado, Denver 61
Testing effectiveness (Phase 2)Study completedNCT02125357
What this trial is testing

Sequencing Abiraterone and Enzalutamide in mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
British Columbia Cancer Agency 202
Large-scale testing (Phase 3)Study completedNCT03016312
What this trial is testing

Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Hoffmann-La Roche 759
Early research (Phase 1)Study completedNCT01911728
What this trial is testing

Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

Who this might be right for
Pharmacokinetics of MDV3100Castration Resistant Prostate Cancer (CRPC)
Astellas Pharma Europe B.V. 14
Testing effectiveness (Phase 2)UnknownNCT02935205
What this trial is testing

Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
Mamta Parikh 38
Testing effectiveness (Phase 2)WithdrawnNCT02159690
What this trial is testing

A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy

Who this might be right for
Prostate CancerLocalized Prostate Cancer
Kenneth Pienta, MD
Early research (Phase 1)Ended earlyNCT05252390
What this trial is testing

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorOvarian CancerOvary Cancer+24 more
Nuvation Bio Inc. 82
Testing effectiveness (Phase 2)Study completedNCT02814968
What this trial is testing

PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide

Who this might be right for
Prostate Cancer Metastatic
The European Uro-Oncology Group 66
Large-scale testing (Phase 3)Ended earlyNCT04409288
What this trial is testing

Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 74
Early research (Phase 1)Study completedNCT02300610
What this trial is testing

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Who this might be right for
Bladder CancerCarcinoma, Transitional CellRenal Pelvis Cancer+2 more
H. Lee Moffitt Cancer Center and Research Institute 10
Not applicableStudy completedNCT02813226
What this trial is testing

Assessment of New Molecular Imaging Strategies for Prostate Cancer

Who this might be right for
Prostate Cancer
Ontario Clinical Oncology Group (OCOG) 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04455750
What this trial is testing

A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
Alliance for Clinical Trials in Oncology 61
Testing effectiveness (Phase 2)UnknownNCT03700099
What this trial is testing

Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Instituto do Cancer do Estado de São Paulo 30
Next Page